# GS-028 October 2 concept batch: editorial receipt

Version `development-batch.2026-10-02.pre-endoscopy.1`. Owner requested20 more
concept groups under the ongoing autonomous authoring contract. Editorial and
technical acceptance completed October2. This document grants no clinical approval: all20
authoring concepts,80 questions,78 case reviews,37 claims and17 sources remain
`needs_clinician_review`, without named clinician sign-off. The runtime is the
local synthetic unapproved owner/development prototype.

## Scope and stable identities

20 distinct scored objectives, four substantive variants each,80 nodes/questions,
78 encounters:76 single-objective encounters and2 paired ultrasound pathways.
284 unique case profiles;288 question-profile references because paired nodes
share patient identity. All20 objectives have independent stage0 clinic access.
Educational difficulty, patient urgency and facility progression remain separate.

| Family | Stable concept IDs |
| --- | --- |
| DCIS | `concept.dcis.margin-bcs-wbrt`; `concept.dcis.sentinel-node-setting` |
| Palpable breast finding | `concept.palpable-breast.negative-mammogram-targeted-us`; `concept.palpable-breast.suspicious-mass-biopsy-despite-negative-imaging` |
| Appendicitis | `concept.appendicitis.stable-adult-ct`; `concept.appendicitis.appendicolith-operative-pathway` |
| Acute cholecystitis | `concept.cholecystitis.hida-after-equivocal-ultrasound`; `concept.cholecystitis.fit-patient-index-admission-cholecystectomy` |
| Mild biliary pancreatitis | `concept.acute-pancreatitis.selective-early-ct`; `concept.acute-pancreatitis.mild-biliary-chole-before-discharge` |
| Acute limb ischemia | `concept.acute-limb-ischemia.viability-exam`; `concept.acute-limb-ischemia.heparin-emergency-transfer` |
| Acute mesenteric ischemia | `concept.acute-mesenteric-ischemia.prompt-cta`; `concept.acute-mesenteric-ischemia.peritonitis-exploration` |
| Malignant colon polyp | `concept.malignant-polyp.low-risk-endoscopic-excision`; `concept.malignant-polyp.adverse-feature-colectomy` |
| Dialysis nutrition | `concept.dialysis-nutrition.hospital-protein-target`; `concept.dialysis-nutrition.avoid-calorie-overfeeding` |
| Post-gastric-surgery ulcers | `concept.retained-antrum.recognition`; `concept.marginal-ulcer.initial-medical-management` |

Patient names materialize through existing generated identities; profiles supply
coherent age/sex and existing characters. Brief complaints and objective-specific
complete prompts support separated presentation/question panels. Answers shuffle.
Parallel options, distractor feedback and no uniquely longest key were reviewed.
Every test/sampling choice, including distractors and future/specialist plans,
has neutral centralized timing. Those durations remain simulation placeholders.

32 urgent cases place the actor in clinic and direct acute care to the hospital.
Eight pancreatitis cases discuss a documented prior hospital course at a stable
clinic visit. No acute hospital CT/HIDA/CTA, anticoagulation or operation becomes
an outpatient service wait. No PN, HIDA or cholecystectomy capability was invented.

Two real breast-ultrasound gates reveal a negative result before asking what to
do with the persistent suspicious examination. Existing in-house/outside routes
are reused. Two standalone ultrasound choices use terminal service orders.
Imaging-occult tissue diagnosis is a breast-specialist referral; the clinic's
image-guided core procedure is not falsely substituted.27 exact correct-test
records cover those4 real services,7 specialist sampling/referral plans,4 future
colonoscopic-surveillance plans and12 hospital-only diagnostic plans.

## Evidence and curriculum

The live owner sheet was refreshed read-only October2 through row168, including
guidance columns I:M, with an empty checked tail through1000:167 candidate rows.
New DCIS and retained-antrum suggestions informed selection. Subtotal
cholecystectomy remains deferred because its intraoperative setting has no real
clinic capability. Blanket supplemental ultrasound for breast density and
later EUS/ROSE suggestions were not used as unsupported early-clinic promises.
No raw sheet export, private notes collection or sheet mutation was created.

Current linked ABSITE/QE outlines were read October2; both retain the January2021
update label. Family-to-organ category mapping is an inference about curriculum
scope, with no recalled item or individual exam-frequency claim. Previously
verified SCORE2025–26 mappings retain their historical access dates. The earlier
blocked SCORE download was not retried. See the
[source contract](../../execplans/gs028-twenty-source-contract-2026-10-02.md).

17 deduplicated bibliographic records support37 independently written atomic
claims, mapped in both directions. Current ASBrS2024/2026, ACR2022, SAGES2024,
ACG2024, ACC/AHA2024, ASCRS2022, ESPEN2024 and ASMBS treatment guidance anchor
the scoped content. Permitted open WSES documents and PCORI's CODA evidence
update provide selected cross-checks. Parent independently read the specified
DCIS, SAGES, pancreatitis, colon, ESPEN and open-atlas facts. PCORI access succeeded
for Terra; parent's fetch error is not represented as independent parent reading.

Single-guidance limits remain for axillary staging, palpable-breast workup,
cholecystitis, ALI/AMI, malignant colon polyp, dialysis nutrition and marginal-ulcer
management. A multisociety document is not multiple independent sources.
Appendicolith changes risk and conditional counseling rather than forbidding
antibiotics universally. Pancreatitis surgery applies to improving mild disease.
The dialysis minimum applies to hospitalized conventional intermittent chronic
KRT without acute or critical illness, using an appropriate reference weight;
the60kg arithmetic example is fictional. It is not a blanket outpatient target.

Retained-antrum content is recognition only, supported by an older2015 narrative
review and a targeted VUMC Global Surgical Atlas cross-check. Precise residual
localization and operative treatment were withheld. The review's actual CC-BY-NC3.0
and atlas's CC-BY-SA3.0 labels are recorded; the limited schema enum does not
justify falsely claiming4.0. Exact license flavor was not reverified for the
DCIS PMC consensus mirror or ASMBS review, so targeted-verification status is used.

Rights-restricted2025 WSES/JAMA appendicitis contents were excluded; bibliographic
currency metadata only informed source selection. ACS AI-restricted material,
NICE, ESPEN2025, inaccessible snippets and proprietary textbooks/banks/SCORE
modules were not ingested. No source prose, excerpts, tables, figures or algorithms
were stored or adapted. Sources separate medical authority from reuse permission.

## Runtime preservation and measured supply

Active runtime:271 concepts/778 cases/1055 nodes, from251/700/975. Prior concepts
and cases compare exactly against the protected pre-admission release. Normalized
baseline SHA256 of `JSON.stringify(value, null, 2) + "\n"`:
`e3d10a7a4da7b43e5828682621b41f76abaae5a9de71d22f0f9c0569be8649cd`.
Final normalized runtime SHA256:
`71fda28a84c9557916d24838395f71c0f1c711a2cc7f1a8e3dcec533c36a90c2`.
Final dated-folder SHA256 of sorted `filename:file-SHA256` lines joined with LF:
`bba685281f61961cb72af2210bb013c4a8dd50a3a66a0206aedeb31bd898d0d7`.
Ignored authoring inventory file SHA256:
`86edcb108dc883145553aaa47d01d6196d367f3b9e62fd6fd77f2e1344f5b633`.
Package timing comprises80 entries with121 timed answer choices, including
all eight high-risk-polyp surveillance/local-excision distractors. The active
global inventory now contains1,346 timed choices and107 terminal correct tests.

Actual before/after supply uses the frozen old release and current release with
the same deterministic ordinary-patient fixtures, excluding employee discussions:

| Fixture | Eligible cases before → after | Eligible objectives before → after |
| --- | --- | --- |
| Beginning/internal stage0 | 355 →433 | 101 →121 |
| Stage1 clinic | 590 →668 | 207 →227 |
| Stage1 reachable ultrasound with technician | 590 →668 | 207 →227 |

Each gains78 encounters/20 objectives. Real selector checks prioritize due
reviews, return none when all candidates are future-due, exclude unresolved
objectives, and select each new objective independently when its other19
siblings are learned and not due. Existing paired eligibility is not bypassed.

No arrival cadence, income, facility price, FSRS due date or existing frozen case
was changed. New objectives expand unseen content; all-not-due campaigns still
need a real due/unseen objective. Synthetic eligibility and earning fixtures do
not establish when the owner's specific campaign can afford Endoscopy.

## Validation and ownership

Final broad affected suite passed221 files/2,166 tests; the separately scoped new
domain suite passed167/167, for2,333 distinct affected tests. Independent final
audit passed1/1 and was repeated by Astra. The three existing ultrasound/service/
exact-order suites passed77/77 (included in broad coverage, not added again).
All eight TypeScript configurations passed, freshly repeated by Astra after the
final source/test edits. Boundaries passed2,508 paths; launcher health contract
passed. Isolated Vite build passed463 modules; the existing large-chunk warning
remains. No owner dist/server substitution was needed.

The new domain harness runs every78 case correctly and wrong/corrected forward,
checks actual terminal acknowledgment/close, Good/Again reviews, balance-defined
XP deltas, replay identity and no duplicate review/XP. Both paired ultrasound
cases use real in-house technician routing, pending serialization and frozen
identity preservation, hidden future result, actual result return and one service
receipt before the external biopsy referral. Both terminal ultrasounds execute
actual onsite operations. Missing staff arranges offsite; busy staff retains the
existing onsite resource queue and completes once released, with one receipt.
No production queue/fallback policy was changed. A synthetic pre-batch serialized
save without the20 new histories gains blank unreviewed histories on load while
every pre-existing history and its frozen encounter remain equal. This is
regression evidence, not inspection of the owner's private save.

Passed browser3/3 on disposable4321 covered
wrong-answer correction, ultrasound pending/reload/return, specialist-referral
feedback, DCIS/dialysis displays and ALI/AMI hospital plans. Browser fixtures used
facility stage2; actual beginning access is a separate domain/metadata check.
Synthetic reducer ticks advanced the real pending/result-return path rather than
waiting150 real game minutes. Page-error assertions passed. Parent inspected
initial, pending-after-reload, returned-all-choices and urgent-feedback images.
Owned test PID54832 was stopped and4321 verified closed; owner4173/4174 untouched.

Reproducible commands (repository root unless noted):

```text
node node_modules/vitest/vitest.mjs run packages/clinical-content packages/game-domain packages/balance-config apps/player --exclude "**/.local-dev/**" --exclude "**/artifacts/**" --exclude "packages/game-domain/tests/gs028-20261002-batch.test.ts" --maxWorkers=2
node node_modules/vitest/vitest.mjs run packages/game-domain/tests/gs028-20261002-batch.test.ts --maxWorkers=1
node node_modules/vitest/vitest.mjs run --config .local-dev/gs028-20261002/vitest.final-release.config.ts --maxWorkers=1
node node_modules/typescript/bin/tsc --noEmit -p <one of the eight workspace tsconfig paths>
node scripts/verify-app-boundaries.mjs
node scripts/verify-launcher-contract.mjs
```

Ignored evidence lives in `.local-dev/gs028-20261002/`: `authoring-final.json`,
`final-audit.json`, `eligibility-after.json`, `broad-vitest-final.log`, final
build/boundary/launcher logs and14 browser images. Do not rerun the old inventory
or eligibility baseline-writing tests after admission; final-release config
only runs the independent new audit. Initial broad failures were repaired by
exact inventory expectations, three deliberately regenerated deterministic
snapshots in two supply tests, and clearer polyp clinic presentation. Narrative
guards, withdrawal allowlists and service/economy rules were not relaxed.
Final parent checks reproduced the167-test domain suite, independent audit and
all eight types. The actual15-file folder fingerprint matches the handoff;
new package/tests contain no detected credential patterns or private inputs.
Scoped diff whitespace check passes with CRLF recognized; the default Git check
otherwise flags existing CRLF historical handoff lines. No unrelated line-ending
cleanup was performed.

Sol `stats_ethics_browser_closeout` authored/repaired the nonurgent half, sources,
assembly and acceptance checks. Sol `oct2_urgent_authoring` authored/repaired the
urgent half, completed browser proof and final167 route/save/review tests.
Terra `stats_ethics_final_audit` independently reviewed/admitted the package and
implemented the160-test initial reducer coverage; unfinished route/save work was
returned then escalated to Sol. Fresh Terra `oct2_release_audit` owns final frozen
release/selector auditing, including all three before/after supply fixtures.
Astra owns scope, source cross-checks, actual file/diff
and image review, acceptance and durable records. No substantial implementation
milestone was left undelegated.

An early mistaken pnpm invocation moved four existing dependencies before a
failed registry attempt; no installation succeeded. Sol restored the missing
original paths outside its assigned ownership, which is recorded in the plan.
Terra independently verified dependencies/workspace junctions and unchanged
package/lock files. Existing Node/npm routes were used afterward.

## Owner pathway and checkpoint

Save & Close/reopen through `START_GAME.cmd` at
**http://127.0.0.1:4173** in the usual persistent profile. The private Tailscale
origin **https://melissadesktop.taile197db.ts.net/** retains separate saves and
its4174 backend. No save migration between origins or cloud synchronization
is implied. No GitHub push, public deployment or clinical promotion occurred.
This is a local checkpoint; say **"push to GitHub"** for the separate scoped,
audited backup. Keep GS028 open for future requested batches.
